Ninghai H. Cheng

Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Quality of life assessment and influencing factors in patients with endometrial cancer and atypical endometrial hyperplasia undergoing fertility-sparing treatment

Quality of life assessment and influencing factors in patients with endometrial cancer and atypical endometrial hyperplasia undergoing fertility-sparing treatment

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: July 21, 2026

Longitudinal trajectories of anxiety and depression in patients with endometrial cancer or atypical endometrial hyperplasia undergoing fertility-sparing treatment.

Longitudinal trajectories of anxiety and depression in patients with endometrial cancer or atypical endometrial hyperplasia undergoing fertility-sparing treatment.

Journal: Gynecologic oncology

Published: February 28, 2026

Autologous hematopoietic stem cell transplantation with TBE conditioning in patients with primary central nervous system lymphoma

Autologous hematopoietic stem cell transplantation with TBE conditioning in patients with primary central nervous system lymphoma

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: December 17, 2025

Fertility-sparing treatment for overweight patients with early-stage endometrial cancer or atypical endometrial hyperplasia under weight loss intervention.

Fertility-sparing treatment for overweight patients with early-stage endometrial cancer or atypical endometrial hyperplasia under weight loss intervention.

Journal: Journal of cancer research and clinical oncology

Published: August 30, 2025

Gonadotropin-releasing hormone agonist plus aromatase inhibitor versus oral progestins for fertility-sparing treatment in early endometrial carcinoma and atypical hyperplasia: interim analysis of a prospective controlled trial.

Gonadotropin-releasing hormone agonist plus aromatase inhibitor versus oral progestins for fertility-sparing treatment in early endometrial carcinoma and atypical hyperplasia: interim analysis of a prospective controlled trial.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: August 25, 2025

Clinical analysis of postmenopausal women with intravenous leiomyomatosis.

Clinical analysis of postmenopausal women with intravenous leiomyomatosis.

Journal: Taiwanese journal of obstetrics & gynecology

Published: July 07, 2025

Patient-reported outcomes after long-term period of niraparib maintenance in platinum-sensitive recurrent ovarian cancer: a prospective, multicenter cohort study.

Patient-reported outcomes after long-term period of niraparib maintenance in platinum-sensitive recurrent ovarian cancer: a prospective, multicenter cohort study.

Journal: Journal of ovarian research

Published: May 21, 2025

Cervical Adenocarcinoma: What's Special About the Long-Term Reproductive and Oncological Outcomes of Fertility-Sparing Radical Trachelectomy in It?

Cervical Adenocarcinoma: What's Special About the Long-Term Reproductive and Oncological Outcomes of Fertility-Sparing Radical Trachelectomy in It?

Journal: Cancer medicine

Published: April 28, 2025

Clinicopathological characteristics,prognosis and related factors of lung cancer arising in the native lung following single lung transplantation

Clinicopathological characteristics,prognosis and related factors of lung cancer arising in the native lung following single lung transplantation

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Published: March 30, 2025

Optimal Levothyroxine Dosing Strategy for Immune Checkpoint Inhibitor-related Hypothyroidism: A Retrospective Study.

Optimal Levothyroxine Dosing Strategy for Immune Checkpoint Inhibitor-related Hypothyroidism: A Retrospective Study.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 17, 2024

Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study.

Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 29, 2024

Toripalimab combined with bevacizumab plus chemotherapy as first-line treatment for refractory recurrent or metastatic cervical cancer: a single-arm, open-label, phase II study (JS001-ISS-CO214).

Toripalimab combined with bevacizumab plus chemotherapy as first-line treatment for refractory recurrent or metastatic cervical cancer: a single-arm, open-label, phase II study (JS001-ISS-CO214).

Journal: Journal of gynecologic oncology

Published: July 19, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026